Previous close | 1.3490 |
Open | 1.3485 |
Bid | 1.3428 |
Day's range | 1.3408 - 1.3527 |
52-week range | 1.3387 - 1.5114 |
Ask | 1.3429 |
BOSTON, May 05, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2022 and reiterated full year 2022 product revenue guidance.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
The best calibre of companies resist competitive threats year-in, year-out, while their competitors fail. This cycle of consistent outperformance and reinvestm...